Skip to main content
. 2013 Aug 23;32(20):2672–2684. doi: 10.1038/emboj.2013.188

Figure 1.

Figure 1

treRNA expression in clinical breast cancer specimens. Each bar represents the percentage of GAPDH-normalized treRNA expression in 12 pairs of primary breast cancer and lymph-node metastasis samples (each pair came from the same patient). The expression of treRNA in the primary breast cancer sample in each pair was scaled to 100% to allow comparison. treRNA expression is significantly higher in the metastasis samples compared with the primary samples (P<0.0001). The geometric mean of the ratio of gene expression levels in the metastatic versus the primary tumour is 3.72 (95% confidence interval is 2.79–4.96).